What Clinicians Need to Know About Therapeutic Options for COVID-19

Medications are available that can reduce chances of severe illness and death from COVID-19. The FDA issued emergency use authorizations for certain antiviral medications and monoclonal antibodies to treat mild to moderate COVID-19 in people who are more likely to get sick. NIH also provides COVID-19 treatment guidelines for healthcare providers for home use or in an outpatient setting. This webinar provides COVID-19 therapeutic options, including indications, efficacy, and distribution.

This video can also be viewed at

Related Articles

5 Essential Frameworks for Preventing Violent Child Death

The U.S. has a violent child death problem. Developing strategies to prevent violent child deaths death from firearms and traffic crashes is a demanding task that requires consideration of numerous upstream, interrelated, and tangential issues. To help safety advocates develop strategies to prevent violent child death, we compiled five frameworks to help: Understand and explain …
The post 5 Essential Frameworks for Preventing Violent Child Death appeared first on Salud America.

What Are the Risk and Protective Factors for Violent Child Death?

Gun violence and traffic crashes may seem like unpredictable events. But they are not random. They are systematic. Data reveal trends and patterns in gun violence and traffic crashes that can help us identify risk factors and protective factors. This is especially important for addressing violent child deaths. So what does the data show? Join …
The post What Are the Risk and Protective Factors for Violent Child Death? appeared first on Salud America.

FDA’s Big Plan to Enhance Public Health in 2025

The Food and Drug Administration (FDA) recently announced its request for $7.2 billion as part of President Joe Biden’s fiscal year (FY) 2025 proposed budget. FDA’s request, which is about 7% higher than last year, covers the agency’s top health priorities. “This funding will allow the agency to enhance food safety and nutrition, advance medical …
The post FDA’s Big Plan to Enhance Public Health in 2025 appeared first on Salud America.

Therapeutic Options to Prevent Severe COVID-19 in Immunocompromised People

The U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorizations (EUA) for monoclonal antibodies to treat COVID-19 for certain patients. Clinicians will learn the FDA’s role in issuing EUAs for certain monoclonal antibodies, options for compassionate use, the process for ordering and distributing monoclonal antibodies, and current data on using monoclonal antibodies for both non-hospitalized and immunocompromised patients. Presenters will also cover preventing, diagnosing, and treating COVID-19 in immunocompromised patients, including the role of monoclonal antibodies, serologic testing, and potential third dose of COVID-19 vaccinations.

This video can also be viewed at
https://emergency.cdc.gov/coca/wmv/2021/081221_video.mp4

Minimize the Impact of COVID-19: Updated Guidance from the CDC

COVID-19 is not over, especially for Latinos. To help people stay vigilant in stopping the spread, the CDC recently published an updated Summary of Guidance for Minimizing the Impact of COVID-19 on Individual Persons, Communities, and Health Care Systems. “To prevent medically significant COVID-19 illness and death, persons must understand their risk, take steps to …
The post Minimize the Impact of COVID-19: Updated Guidance from the CDC appeared first on Salud America.

Responses